Chris Pan

Stock Analyst at Goldman Sachs

(1.96)
# 3,355
Out of 4,792 analysts
41
Total ratings
45.2%
Success rate
1%
Average return

Stocks Rated by Chris Pan

Hangzhou Tigermed Consulting Co., Ltd
Aug 30, 2026
Reiterated: Buy
Price Target: $61.40$52.10
Current: $41.76
Upside: +24.76%
AK Medical Holdings Limited
Aug 27, 2026
Reiterated: Buy
Price Target: $8.40$7.60
Current: $4.92
Upside: +54.63%
Shandong Weigao Group Medical Polymer Company Limited
Aug 26, 2026
Reiterated: Hold
Price Target: $4.00$3.86
Current: $3.15
Upside: +22.54%
MicroTech Medical (Hangzhou) Co., Ltd.
Apr 26, 2026
Upgraded: Hold
Price Target: $6.60$8.90
Current: $6.60
Upside: +34.85%
Shanghai MicroPort MedBot (Group) Co., Ltd.
Apr 21, 2026
Initiated Coverage: Buy
Price Target: $45.00
Current: $21.18
Upside: +112.46%
Shenzhen Edge Medical Co., Ltd.
Apr 21, 2026
Initiated Coverage: Buy
Price Target: $81.00
Current: $35.72
Upside: +126.76%
Angelalign Technology Inc.
Aug 26, 2025
Reiterated: Buy
Price Target: $76.20$81.30
Current: $91.25
Upside: n/a
Venus Medtech (Hangzhou) Inc.
Sep 6, 2024
Rated: Hold
Price Target: n/a
Current: $1.21
Upside: n/a
Shanghai HeartCare Medical Technology Corporation Limited
Jul 19, 2024
Reiterated: Buy
Price Target: $29.80$25.60
Current: $48.82
Upside: n/a
Gushengtang Holdings Limited
Apr 19, 2024
Upgraded: Buy
Price Target: $55.00$61.00
Current: $26.60
Upside: n/a